Enveric Biosciences, Inc. ENVB 深 滬
已收盤 08-07 16:00:00 美东时间
1.55
-0.010
-0.64%
華盛通- 最 高1.63
- 今 開1.60
- 成交量 4.93万股
- 最 低 1.53
- 昨 收 1.56
- 總市值 624.41万
- 52周最高 17.64
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.25
- 委 比 95.16%
- 總股本 402.85万
- 歷史最高 2700000.00
- 量 比 0.25
- 振 幅 6.41%
- 歷史最低 1.25
- 每 手 1
- 風險率 3.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Enveric Biosciences将出席B. Riley证券峰会 聚焦神经精神药物开发
生物技术公司Enveric Biosciences周一宣布，将参与B． Riley证券举办的Mind， Muscle & Vision峰会。公司首席...
06-30 03:23
Enveric Biosciences Expands At-The-Market Equity Offering
Enveric Biosciences ( ($ENVB) ) just unveiled an update. On June 9, 2026, Enver...
06-10 06:51
Enveric Biosciences Releases Updated Investor Presentation Materials
An update from Enveric Biosciences ( ($ENVB) ) is now available. Enveric Biosci...
06-09 18:47
Enveric Biosciences Initiates Investigational New Drug-enabling Genotoxicity Studies Of EB-003
Studies are designed to evaluate the potential for the compound to interact with DNA and cause genetic mutations, a critical measure of safety required for IND submission
06-02 20:10
Enveric Biosciences shares are trading lower. The company announced preclinical in vitro results showing no photoreactive potential for EB‑003, further derisking its neuropsychiatric program.
Enveric Biosciences shares are trading lower. The company announced preclinical...
05-20 01:34
Enveric Biosciences Q1 EPS $(1.08) Up From $(14.64) YoY
Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(1.08) per share. This is a 92.62 percent increase over losses of $(14.64) per share from the same period last year.
05-15 20:16
Enveric Biosciences Highlights Results for EB-003 In PTSD Preclinical Model; Says Previously Reported Results Support Continued Development Of EB-003 For PTSD, Other Neuropsychiatric Condition
Enveric Biosciences today highlighted preclinical data for its lead candidate, EB-003, a dual 5-HT2A and 5-HT1B modulator, in which a single dose of EB-003 significantly reduced context-induced freezing behavior one hour
05-05 20:00
Enveric Biosciences Corrects Reverse Stock Split Proxy Disclosure
The latest announcement is out from Enveric Biosciences ( ($ENVB) ). On April 1...
05-01 05:31
